DR. LAXMI DEVI

About

Dr. Laxmi Devi, Her main area of research is pharmaceutical nanotechnology and its biomedical applications, with a specialization in drug delivery for various targeted diseases, including cancer. She obtained her M.Pharm. in Pharmaceutics from Bundelkhand University, Jhansi, and is pursuing a Ph.D. in Pharmaceutics while also working as an associate professor. She has 8 years of teaching and research experience. Her area of interest includes the application of various nanocarriers for drug delivery.

Employment

• Faculty of Pharmacy,kamla Nehru Institute of Management &Technology Associate Professor
  2025 - Present
• Smt. Vidyawati college of Pharmacy, Associate Professor
  2023 - 2025
• RAMESHWARM INSTITUTE OF TECHNOLOGY AND MANAGEMENT Assistant Professor
  2019 - 2023

Education

• Integral University PhD
  2021 - 2025
• IGNOU Post Graduate Diploma in Intellectual Property Rights
  2019 - 2020
• Bundelkhand University M.pharma
  2015 - 2017
• Bundelkhand University B.pharma
  2011 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Plant‐derived Anticancer Molecules as Novel Outlook in the Management of Cancers: An In silico and Pharmacophore‐based Approaches
  Plant‐derived Anticancer Drugs 2025 DOI: 10.1002/9781394300594.ch07
  +Save
• Eco-friendly Synthesis of Azadirachta indica-based Metallic Nanoparticles for Biomedical Application & Future Prospective
  Pharmaceutical Nanotechnology 2025 DOI: 10.2174/0122117385262947240206055107
  +Save
• Synthesis and Characterization of Acacia-Stabilized Doxorubicin-Loaded Gold Nanoparticles for Breast Cancer Therapy
  Drug Research 2025 DOI: 10.1055/a-2418-2200
  +Save
• Recent Trends in Biologically Synthesized Metal Nanoparticles and their Biomedical Applications: a Review
  Biological Trace Element Research 2024 DOI: 10.1007/s12011-023-03920-9
  +Save
• New Advances in the Biomedical Applications of Nanoparticles as Novel Drug Delivery Carriers
  Nanoparticles as a drug delivery carriers 2024
  +Save
• Metallic (Inorganic) Nanoparticles
  Metallic Nanoparticles for Health and the Environment 2023 DOI: 10.1201/9781003317319-1
  +Save
• Assessment of gemcitabine hydrochloride-based nanotherapeutics in cancer: a proof of concept study
  Journal of Nanoparticle Research 2023 DOI: 10.1007/s11051-023-05764-9
  +Save
• Regulatory pathway to introduce a nanomedicine product in the market at international level
  Theory and Applications of Nonparenteral Nanomedicines 2021 DOI: 10.1016/b978-0-12-820466-5.00020-x
  +Save
• Synthesis, characterization and in vitro assessment of colloidal gold nanoparticles of Gemcitabine with natural polysaccharides for treatment of breast cancer
  Journal of Drug Delivery Science and Technology 2020 DOI: 10.1016/j.jddst.2020.101565
  +Save